Efficacy of Intravenous Dexketoprofen and Tenoxicam on Propofol Associated Injection Pain

NCT ID: NCT02285972

Last Updated: 2015-04-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

118 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2015-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Propofol remains the most common drug for induction of general anaesthesia, although it causes considerable pain or discomfort on injection. Anesthesia providers have attempted a large number of remedies to prevent this pain on injection. Previously explored ideas include injecting propofol into larger veins, warming of the hand with hot packs, and intravenous pretreatment with numerous other medications. No studies to date have looked at the dexketoprofen and tenoxicam for the pretreatment of pain on injection caused by propofol. The investigators propose studying the use of dexketoprofen and tenoxicam for pretreatment of propofol related pain on injection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Injection Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

saline

Group Type PLACEBO_COMPARATOR

saline

Intervention Type DRUG

before the anesthesia induction, 2mL saline iv injection

dexketoprofen

Group Type ACTIVE_COMPARATOR

dexketoprofen

Intervention Type DRUG

before the anesthesia induction, 50 mg (2mL) iv dexketoprofen

tenoxicam

Group Type ACTIVE_COMPARATOR

tenoxicam

Intervention Type DRUG

before the anesthesia induction, 20 mg (2mL) iv tenoxicam

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

saline

before the anesthesia induction, 2mL saline iv injection

Intervention Type DRUG

dexketoprofen

before the anesthesia induction, 50 mg (2mL) iv dexketoprofen

Intervention Type DRUG

tenoxicam

before the anesthesia induction, 20 mg (2mL) iv tenoxicam

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

serum physiologic Arveles Leodex Oksamen-L Tilcotil

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* American Society of Anesthesiologists (ASA) physical status 1 and 2
* 18 - 65 years
* general anesthesia scheduled for elective surgery

Exclusion Criteria

* age \< 18 years, \> 65 years
* pregnancy
* patients requiring a rapid sequence induction
* refusal to participate and patients already participating in another study
* allergy to study drugs
* communication difficulty
* psychiatric and neurolojic disorders
* use of analgesics or sedative drugs within 24 hours before surgery.
* emergency surgery
* history of drug or alcohol abuse
* ASA 3 and above
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ordu University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

özgür yağan

MD, assistant professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Anesthesiology and Reanimation Dept. Ordu University Training and Research Hospital

Altinordu, Ordu, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Odu-5

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.